نتائج البحث 631-640 من 6459 لعملية البحث عن treatment resistant depression
... treatment, while rates of disease control during Induction have not improved ... resistance to 131I-MIBG and crizotinib. A Study to Evaluate the Effectiveness and ...
Invasive lobular cancer and treatment choices. 42 Replies Thu, Mar 07, 2024. diane12 · Fear of radiation after lumpectomy. 124 Replies Thu, Mar 07, 2024.
The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...
ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.
In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in combination with doxorubicin (Arm 2) ...
https://www.fda.gov/consumers/consumer-updates/how-gene-therapy-can-cure-or-treat-diseases. Accessed Feb. 8, 2024. Gene therapy basics. American Society of Gene ...
Whole brain radiotherapy (WBRT) is the most common treatment for brain metastasis. ... Radiation therapy uses high energy x-rays to kill tumor cells and shrink ...
... treatment-related side effects, and improve immune function. ... treatment, and assess infection rates. ... The purpose of phase 2a is to establish proof-of ...
Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia. Evaluating Markers which Might be a ...
The purpose of the Pediatric Proton Consortium Registry (PPCR) is to enroll children who have been treated with proton radiation in the United States in ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.